Literature DB >> 31062171

14-3-3/Tau Interaction and Tau Amyloidogenesis.

Yuwen Chen1,2,3, Xingyu Chen1,2,3, Zhiyang Yao1,2,3, Yuqi Shi1,2,3, Junwen Xiong1,2,3, Jingjing Zhou1,2,3, Zhengding Su4,5,6,7, Yongqi Huang8,9,10,11.   

Abstract

The major function of microtubule-associated protein tau is to promote microtubule assembly in the central nervous system. However, aggregation of abnormally phosphorylated tau is a hallmark of tauopathies. Although the molecular mechanisms of conformational transitions and assembling of tau molecules into amyloid fibril remain largely unknown, several factors have been shown to promote tau aggregation, including mutations, polyanions, phosphorylation, and interactions with other proteins. 14-3-3 proteins are a family of highly conserved, multifunctional proteins that are mainly expressed in the central nervous system. Being a scaffolding protein, 14-3-3 proteins interact with tau and regulate tau phosphorylation by bridging tau with various protein kinases. 14-3-3 proteins also directly regulate tau aggregation via specific and non-specific interactions with tau. In this review, we summarize recent advances in characterization of tau conformation and tau/14-3-3 interaction. We discuss the connection between 14-3-3 binding and tau aggregation with a special emphasis on the regulatory role of 14-3-3 on tau conformation.

Entities:  

Keywords:  14-3-3 proteins; Alzheimer’s disease; Protein aggregation; Tau protein; Tauopathies

Mesh:

Substances:

Year:  2019        PMID: 31062171     DOI: 10.1007/s12031-019-01325-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  129 in total

Review 1.  14-3-3 proteins: structure, function, and regulation.

Authors:  H Fu; R R Subramanian; S C Masters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

Authors:  M von Bergen; P Friedhoff; J Biernat; J Heberle; E M Mandelkow; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  14-3-3zeta is an effector of tau protein phosphorylation.

Authors:  M Hashiguchi; K Sobue; H K Paudel
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

4.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation.

Authors:  S R Datta; A Katsov; L Hu; A Petros; S W Fesik; M B Yaffe; M E Greenberg
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

5.  Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

Authors:  M E King; V Ahuja; L I Binder; J Kuret
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

6.  A protein factor essential for microtubule assembly.

Authors:  M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

7.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

8.  Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.

Authors:  A Schneider; J Biernat; M von Bergen; E Mandelkow; E M Mandelkow
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

9.  Sequence Data Analysis for Long Disordered Regions Prediction in the Calcineurin Family.

Authors: 
Journal:  Genome Inform Ser Workshop Genome Inform       Date:  1997

10.  Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins.

Authors:  L Zhang; J Chen; H Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

View more
  6 in total

Review 1.  14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation.

Authors:  Xianlong Huang; Zhiwen Zheng; Yixin Wu; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Biochem Biophys       Date:  2022-02-10       Impact factor: 2.989

2.  Uba1: A Potential Ubiquitin-like Activator Protein of Urm1 in Toxoplasma gondii.

Authors:  Qianqian Xiao; Jinxuan Li; Junpeng Chen; Qianqian Tan; Xiao Chen; Hongmei Li; Xiaomin Zhao; Xiao Zhang
Journal:  Int J Mol Sci       Date:  2022-09-07       Impact factor: 6.208

3.  Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum.

Authors:  Yuanyuan Lu
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

4.  Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.

Authors:  Niko Hensel; Federica Cieri; Pamela Santonicola; Ines Tapken; Tobias Schüning; Michela Taiana; Elisa Pagliari; Antonia Joseph; Silke Fischer; Natascha Heidrich; Hella Brinkmann; Sabrina Kubinski; Anke K Bergmann; Manuela F Richter; Klaus Jung; Stefania Corti; Elia Di Schiavi; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

5.  Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.

Authors:  Antonio Dominguez-Meijide; Eftychia Vasili; Annekatrin König; Maria-Sol Cima-Omori; Alain Ibáñez de Opakua; Andrei Leonov; Sergey Ryazanov; Markus Zweckstetter; Christian Griesinger; Tiago F Outeiro
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

6.  α-Synuclein modulates tau spreading in mouse brains.

Authors:  Fares Bassil; Emily S Meymand; Hannah J Brown; Hong Xu; Timothy O Cox; Shankar Pattabhiraman; Chantal M Maghames; Qihui Wu; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.